2,728
Views
5
CrossRef citations to date
0
Altmetric
APPLIED SPORT SCIENCES

Repeated sprint cycling performance is not enhanced by ischaemic preconditioning or muscle heating strategies

ORCID Icon, ORCID Icon, , , , & show all

Figures & data

Figure 1. Schematic of experimental protocol detailing the order of events on each laboratory visit.

Figure 1. Schematic of experimental protocol detailing the order of events on each laboratory visit.

Figure 2. (a) Typical NIRS muscle oxygenation data during 10 × 6-s all-out sprints and (b), an example of a single 6-s sprint, followed by a 24-s recovery. Assessment of NIRS data during sprints was obtained from the first 7 s of effort, accounting for any additional pedal strokes. Deoxygenation amplitude (DeoxyAMP) and slope (Deoxyslope) were calculated from the maximal (TOImax) and minimal (TOImin) values (horizontal solid lines). Time Delay (TD) was defined as the time (s) from post-sprint to the beginning of muscle reoxygenation. Mean TD was 2.11 ± 0.95 s. Recovery amplitude (ReoxyAMP) and rate (Reoxyslope) were calculated from maximal (recTOImax) and minimal (recTOImin) values (horizontal dashed lines). TOI; Tissue oxygenation index, S1-10; Sprint number.

Figure 2. (a) Typical NIRS muscle oxygenation data during 10 × 6-s all-out sprints and (b), an example of a single 6-s sprint, followed by a 24-s recovery. Assessment of NIRS data during sprints was obtained from the first 7 s of effort, accounting for any additional pedal strokes. Deoxygenation amplitude (DeoxyAMP) and slope (Deoxyslope) were calculated from the maximal (TOImax) and minimal (TOImin) values (horizontal solid lines). Time Delay (TD) was defined as the time (s) from post-sprint to the beginning of muscle reoxygenation. Mean TD was 2.11 ± 0.95 s. Recovery amplitude (ReoxyAMP) and rate (Reoxyslope) were calculated from maximal (recTOImax) and minimal (recTOImin) values (horizontal dashed lines). TOI; Tissue oxygenation index, S1-10; Sprint number.

Table I. Peak and average power comparisons between conditions, accompanied with the likelihood of “beneficial”, “trivial” or “unlikely” performance outcomes.

Table II. Muscle NIRS (deoxygenation [DeoxyAMP (%) and Deoxyslope (% s−1)] and reoxygenation [ReoxyAMP (%) and Reoxyslope (% s−1)] characteristics) and EMG (RMS% activity) for 10 × 6-s repeated sprints between conditions.